Table 2.

Competing risks regression model for transition from CVC to fistula or graft among the study population, shown as sHRs and 95% CIs

Patient Characteristics	Overall, n=74,194			Men, n=39,132			Women, n=35,062
	Fistula	Graft	Fistula or Graft	Fistula	Graft	Fistula or Graft	Fistula	Graft	Fistula or Graft
Race/ethnicity (reference: white)
Black	0.88	1.80	1.13	0.88	1.97	1.10	0.89	1.69	1.16
	[0.85 to 0.91]	[1.70 to 1.90]	[1.10 to 1.16]	[0.84 to 0.92]	[1.81 to 2.14]	[1.06 to 1.15]	[0.85 to 0.94]	[1.58 to 1.82]	[1.11 to 1.21]
Hispanic	1.17	1.06	1.15	1.17	1.01	1.14	1.17	1.09	1.16
	[1.12 to 1.22]	[0.97 to 1.15]	[1.11 to 1.19]	[1.10 to 1.24]	[0.89 to 1.16]	[1.08 to 1.20]	[1.10 to 1.25]	[0.98 to 1.21]	[1.10 to 1.23]
Other race	1.23	1.39	1.33	1.18	1.61	1.32	1.29	1.25	1.34
	[1.16 to 1.30]	[1.27 to 1.53]	[1.26 to 1.39]	[1.09 to 1.27]	[1.40 to 1.86]	[1.23 to 1.41]	[1.19 to 1.40]	[1.10 to 1.42]	[1.25 to 1.43]
Female sex (reference: male)	0.81	1.48	0.96
	[0.79 to 0.83]	[1.42 to 1.55]	[0.93 to 0.98]
Age category, yr (reference: 66–70 yr)
71–75	0.96	1.06	0.99	0.97	1.10	1.00	0.95	1.04	0.97
	[0.93 to 0.99]	[1.00 to 1.13]	[0.96 to 1.02]	[0.92 to 1.01]	[1.00 to 1.21]	[0.96 to 1.04]	[0.90 to 0.99]	[0.96 to 1.13]	[0.94 to 1.02]
76–80	0.91	1.134	0.97	0.92	1.21	0.98	0.89	1.10	0.95
	[0.88 to 0.94]	[1.07 to 1.21]	[0.94 to 1.00]	[0.88 to 0.96]	[1.10 to 1.33]	[0.94 to 1.02]	[0.85 to 0.94]	[1.01 to 1.19]	[0.91 to 0.97]
≥81	0.77	1.15	0.86	0.78	1.35	0.89	0.76	1.04	0.83
	[0.75 to 0.80]	[1.08 to 1.22]	[0.83 to 0.89]	[0.75 to 0.82]	[1.23 to 1.48]	[0.85 to 0.93]	[0.72 to 0.80]	[0.96 to 1.12]	[0.79 to 0.86]
Needs ADL assistance (reference: no)	0.80	0.99	0.84	0.78	0.95	0.80	0.83	1.01	0.87
	[0.77 to 0.83]	[0.93 to 1.05]	[0.81 to 0.86]	[0.74 to 0.82]	[0.86 to 1.05]	[0.76 to 0.83]	[0.79 to 0.88]	[0.94 to 1.09]	[0.84 to 0.91]
Hospitalized in the past year (reference: no)	0.92	1.05	0.94	0.95	1.04	0.96	0.89	1.06	0.93
	[0.90 to 0.94]	[1.00 to 1.10]	[0.92 to 0.96]	[0.92 to 0.98]	[0.97 to 1.11]	[0.93 to 0.99]	[0.85 to 0.92]	[1.00 to 1.12]	[0.90 to 0.96]
Institutionalized (reference: no)	0.67	0.91	0.70	0.68	0.91	0.70	0.65	0.90	0.70
	[0.64 to 0.70]	[0.85 to 0.97]	[0.67 to 0.72]	[0.64 to 0.72]	[0.82 to 1.01]	[0.67 to 0.74]	[0.61 to 0.69]	[0.83 to 0.98]	[0.66 to 0.73]
Received pre-ESKD nephrology care (reference: no)	1.31	1.17	1.34	1.31	1.16	1.33	1.32	1.18	1.34
	[1.28 to 1.35]	[1.11 to 1.23]	[1.30 to 1.37]	[1.26 to 1.36]	[1.07 to 1.25]	[1.29 to 1.38]	[1.26 to 1.37]	[1.10 to 1.26]	[1.30 to 1.39]

Exponentiated coefficients; 95% CIs in brackets. Covariates included age, race/ethnicity, sex, body mass index, peripheral arterial disease, congestive heart failure, atherosclerotic heart disease, other cardiac disease, diabetes, creatinine, GFR, pre-ESKD nephrology care, functional status, hospitalization within the past year, institutionalization, income, US Renal Data System network, rurality, and Medicaid enrollment. ADL, activities of daily living.